Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Kelp, a type of brown seaweed, has gained attention in recent years as a potential supplement for supporting liver health, including in the context of Fatty Liver Disease (Non-Alcoholic Fatty Liver Disease, NAFLD). There is some preliminary scientific evidence suggesting that compounds found in kelp, such as fucoxanthin, alginates, and polyphenols, may exert beneficial effects on lipid metabolism, inflammation, and oxidative stress — all of which are relevant factors in NAFLD. Animal studies have shown that fucoxanthin can help reduce hepatic fat accumulation and improve markers of liver function. For example, a 2012 study in mice found that dietary fucoxanthin reduced body weight gain and liver fat content. Other research has demonstrated antioxidant and anti-inflammatory properties of kelp extracts, which could theoretically provide liver-protective effects.

However, human clinical trials are very limited, and the available studies are often small or use mixed seaweed extracts, making it difficult to isolate the effects of kelp itself. Systematic reviews generally conclude that while there is promise, the evidence base remains insufficient for strong recommendations regarding kelp supplementation for fatty liver disease. Thus, kelp's use in this context is justified by emerging but not robust scientific evidence, and it should not replace conventional management. People with thyroid disorders or those taking certain medications should be cautious, as kelp is high in iodine and may interact with thyroid function.

More about kelp
More about Fatty Liver Disease

Other ingredients used for Fatty Liver Disease

Other health conditions supported by kelp

Products containing kelp

YH International Barleygreen
YH International Barleygreen (with Kelp)
Vitabase Super Fat Burner